PATENT CLAIM ANALYSIS

Application Number: 15909521
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["544", "331000"]

Abstract:
The present invention includes novel compounds and methods for preventing or treating diseases associated with and/or caused by overexpression and/or uncontrolled activation of a tyrosine kinase in a subject in need thereof. In certain embodiments, the compounds of the present invention comprise a tyrosine kinase inhibitor, a linker and a ubiquitin ligase binder. The methods of the present invention comprise administering to the subject an pharmaceutically effective amount of at least one compound of the invention.

Claim (Index 31):
The method of  claim 25 , wherein the compound is administered to the subject by at least one route selected from the group consisting of nasal, inhalational, topical, oral, buccal, rectal, pleural, peritoneal, vaginal, intramuscular, subcutaneous, transdermal, epidural, intrathecal and intravenous routes.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 90.0
- Lexical Diversity: 1.58824
- Patent Class: 544.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15341275', '14822309', '13211026', '15881318', '15400766']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8056923036180579
- 35 USC 102 Novelty (BERT): 0.6047272261749794
- Combined Prediction Score: 0.7855957958737501
- Mean Citation Score: 345.960142
- Max Citation Score: 831.4325
- Similarity Product: 463.71491365641367

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test